AU2001240521A1 - (ca)n polymorphisms in an intron of the endothelial nitric oxide synthase gene and their use in diagnostic and therapeutic applications - Google Patents

(ca)n polymorphisms in an intron of the endothelial nitric oxide synthase gene and their use in diagnostic and therapeutic applications

Info

Publication number
AU2001240521A1
AU2001240521A1 AU2001240521A AU4052101A AU2001240521A1 AU 2001240521 A1 AU2001240521 A1 AU 2001240521A1 AU 2001240521 A AU2001240521 A AU 2001240521A AU 4052101 A AU4052101 A AU 4052101A AU 2001240521 A1 AU2001240521 A1 AU 2001240521A1
Authority
AU
Australia
Prior art keywords
polymorphisms
intron
diagnostic
nitric oxide
therapeutic applications
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001240521A
Inventor
Ingolf Cascorbi
Ivar Roots
Karl Stangl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Epidauros Biotechnologie AG
Original Assignee
Epidauros Biotechnologie AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Epidauros Biotechnologie AG filed Critical Epidauros Biotechnologie AG
Publication of AU2001240521A1 publication Critical patent/AU2001240521A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2001240521A 2000-01-20 2001-01-19 (ca)n polymorphisms in an intron of the endothelial nitric oxide synthase gene and their use in diagnostic and therapeutic applications Abandoned AU2001240521A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00101109.7 2000-01-20
EP00101109 2000-01-20
PCT/EP2001/000593 WO2001053522A2 (en) 2000-01-20 2001-01-19 (CA)n POLYMORPHISMS IN AN INTRON OF THE ENDOTHELIAL NITRIC OXIDE SYNTHASE GENE AND THEIR USE IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS

Publications (1)

Publication Number Publication Date
AU2001240521A1 true AU2001240521A1 (en) 2001-07-31

Family

ID=8167671

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001240521A Abandoned AU2001240521A1 (en) 2000-01-20 2001-01-19 (ca)n polymorphisms in an intron of the endothelial nitric oxide synthase gene and their use in diagnostic and therapeutic applications

Country Status (2)

Country Link
AU (1) AU2001240521A1 (en)
WO (1) WO2001053522A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2566257A1 (en) * 2004-05-07 2005-11-24 Applera Corporation Genetic polymorphisms associated with vascular diseases, methods of detection and uses thereof
CN106290926A (en) * 2016-08-13 2017-01-04 山东博科生物产业有限公司 A kind of apolipoprotein B immunoturbidimetry detection kit
CN116790603B (en) * 2023-08-18 2023-10-31 成都中科奥格生物科技有限公司 sgRNA and CRISPR/Cas9 vector as well as construction method and application thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9810085D0 (en) * 1998-05-11 1998-07-08 Gemini Research Limited Polymorphism in a nitric oxide synthase gene

Also Published As

Publication number Publication date
WO2001053522A2 (en) 2001-07-26
WO2001053522A3 (en) 2002-07-25

Similar Documents

Publication Publication Date Title
AU2001293553A1 (en) Phosphatidylserine-carrying apoptosis-mimicking bodies and the use thereof in medical treatment
AU2003208228A1 (en) Formulations and methods of using nitric oxide mimetics in cancer treatment
AU2003284388A1 (en) Organellar targeting of rna and its use in the interruption of environmental gene flow
AU2002308348A1 (en) Ganglioside-associated recombinant antibodies and the use thereof in the diagnosis and treatment of tumours
AU2002315168A1 (en) Combination therapy of gamma-interferon and b cell specific antibodies
AU5618501A (en) Dihydropyrimidines and the use thereof as medicaments for the treatment of hepatitis
AU2002247208A1 (en) Selective pde3b inhibitors and use of the same in therapy
AU2002306308A1 (en) sd1 gene involved in plant semidwarfing and uses thereof
AU2002305151A1 (en) Gene scc-112 and diagnostic and therapeutic uses thereof
AU2002303261A1 (en) Gene brcc2 and diagnostic and therapeutic uses thereof
HUP0201997A2 (en) Polymorphisms in the human mdr-1 gene and their use in diagnostic and therapeutic applications
HK1081864A1 (en) Anti-inflammatory compositions and use of the same in the manufacture of medicaments
AU2003274905A1 (en) Recombinant double-stranded rna phage, and use of the same
AU2002365188A1 (en) Nucleic acid delivery and expression
AU2001234538A1 (en) Nitric oxide synthase gene diagnostic polymorphisms
AU2003298551A8 (en) Nitric oxide and its biomedical significance
AU2001240521A1 (en) (ca)n polymorphisms in an intron of the endothelial nitric oxide synthase gene and their use in diagnostic and therapeutic applications
EP1225913B8 (en) Use of nitric oxide for the treatment of airway constriction
AU2003240253A1 (en) Polymorphisms in the human gene for htr3b and their use in diagnostic and therapeutic applications
AU2003244498A1 (en) Polymorphisms in the human gene for tpmt and their use in diagnostic and therapeutic applications
AU2002254524A1 (en) Use of semenogelin in the diagnosis, prognosis and treatment of cancer
AU2002355470A1 (en) Polymorphisms in the human gene for cyp1a2 and their use in diagnostic and therapeutic applications
AU2002240094A1 (en) Anti-apoptopic gene scc-s2 and diagnostic and therapeutic uses thereof
AU2001260291A1 (en) Combination of cerivastatin with ace inhibitors and the use thereof in medicaments
AU2001289861A1 (en) Polymorphisms in human genes of cardiovascular regulators and their use in diagnostic and therapeutic applications